Citadel Advisors - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,570,046
-21.1%
76,105
+12.9%
0.00%
Q2 2023$1,989,063
-93.9%
67,403
-95.2%
0.00%
-100.0%
Q1 2023$32,457,024
+1586.2%
1,408,725
+1935.3%
0.01%
Q4 2022$1,924,814
-27.5%
69,213
-20.0%
0.00%
Q3 2022$2,656,000
-72.9%
86,537
-74.0%
0.00%
-100.0%
Q2 2022$9,783,000
-60.0%
332,402
-56.3%
0.00%
-60.0%
Q1 2022$24,488,000
+2.0%
761,203
+41.4%
0.01%
+25.0%
Q4 2021$24,008,000
+358.8%
538,283
+419.0%
0.00%
+300.0%
Q3 2021$5,233,000
+101.0%
103,711
+212.4%
0.00%
Q2 2021$2,604,000
-83.5%
33,200
-88.0%
0.00%
-100.0%
Q1 2021$15,765,000
+254.3%
276,084
+419.8%
0.00%
+200.0%
Q4 2020$4,449,000
-48.2%
53,113
-77.8%
0.00%
-50.0%
Q3 2020$8,583,000
+221.1%
239,537
+116.6%
0.00%
+100.0%
Q2 2020$2,673,000
+80.4%
110,565
+30.6%
0.00%0.0%
Q1 2020$1,482,000
+27.4%
84,652
+26.8%
0.00%
Q4 2019$1,163,000
-23.8%
66,786
-33.0%
0.00%
-100.0%
Q3 2019$1,526,000
-62.3%
99,609
-48.9%
0.00%
-50.0%
Q2 2019$4,045,000
+527.1%
194,876
+601.9%
0.00%
Q1 2019$645,000
-14.3%
27,765
-43.8%
0.00%
Q2 2018$753,00049,4210.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders